Skip to main content

Advertisement

Log in

Dehydroepiandrosterone sulfate levels in Turkish obese patients

  • Brief Report
  • Published:
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity Aims and scope Submit manuscript

Abstract

Purpose

Obesity is well known to be linked to higher morbidity and mortality. Elevated plasma levels of free dehydroepiandrosterone (DHEA) are associated with reduced obesity and more limited accumulation of abdominal body fat. In contrast, the relationship between the DHEA sulfate ester (DHEAS) and adiposity is inconsistent and contradictory.

Methods

The aim of this study was to compare DHEAS levels in obese Turkish individuals, 37 men and 246 women. A variety of fatness, hormone, and blood parameters were measured.

Results

Statistically significant differences were found between male and female individuals with respect to weight, waist circumference, fat %, insulin, and DHEAS levels.

Conclusions

We found that in the Turkish population, while a correlation between obesity parameters and DHEAS levels exists in both female and male individuals, DHEAS levels are significantly higher in obese male individuals than in obese female individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Abbasi A, Duthie EH, Sheldahl L et al (1998) Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women. J Am Geriatr Soc 46(3):263–273

    CAS  PubMed  Google Scholar 

  2. Barrett-Connor E, Ferrara A (1996) Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 81(1):59–64

    CAS  PubMed  Google Scholar 

  3. Baulieu EE (2002) Androgens and aging men. Mol Cell Endocrinol 198:41–49

    Article  CAS  PubMed  Google Scholar 

  4. Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763

    Article  CAS  PubMed  Google Scholar 

  5. Berr C, Lafont S, Debuire B et al (1996) Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 93(23):13410–13415

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Butcher SK, Lord JM (2004) Stress responses and innate immunity: aging as a contributory factor. Aging Cell 3(4):151–160

    Article  CAS  PubMed  Google Scholar 

  7. Celec P, Starka L (2003) Dehydroepiandrosterone—is the fountain of youth drying out? Physiol Res 52(4):397–407

    CAS  PubMed  Google Scholar 

  8. Chen MJ, Chen CD, Yang JH, Chen CL, Ho HN, Yang WS, Yang YS (2011) High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome. Hum Rep 26(1):227–234

    Article  CAS  Google Scholar 

  9. Feldman HA, Johannes CB, Araujo AB et al (2001) Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts male aging study. Am J Epidemiol 153(1):79–89

    Article  CAS  PubMed  Google Scholar 

  10. Friess E, Schiffelholz T, Steckler T, Steiger A (2000) Dehydroepiandrosterone—a neurosteroid. Eur J Clin Invest 30(3):46–50

    Article  CAS  PubMed  Google Scholar 

  11. Glei DA, Goldman N, Weinstein M et al (2004) Dehydroepiandrosterone sulfate (DHEAS) and health: does the relationship differ by sex? Exp Gerontol 39(3):321–331

    Article  CAS  PubMed  Google Scholar 

  12. Himes CL (2000) Obesity, disease, and functional limitation in later life. Demography 37(1):73–82

    Article  CAS  PubMed  Google Scholar 

  13. Hsieh CCSL, Lipworth L, Lagiou P, Mantzoros CS, Trichopoulos D (1998) Predictors of sex hormone levels among the elderly: a study in Greece. J Clin Epidemiol 51(10):837–841

    Article  CAS  PubMed  Google Scholar 

  14. Kawai S, Yahata N, Nishida S, Mizushima Y (1995) Dehydroepiandrosterone inhibits B16 mouse melanoma cell growth by induction of differentiation. Anticancer Res 15(2):427–431

    CAS  PubMed  Google Scholar 

  15. Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74:761–811

    CAS  PubMed  Google Scholar 

  16. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J et al (1998) DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 63:322–328

    Article  CAS  PubMed  Google Scholar 

  17. Labrie F, Luu-The V, Bélanger A, Lin S-X, Simard J, Pelletier G, Labrie C (2005) Is dehydroepiandrosterone a hormone? J Endocrinol 187:169–196

    Article  CAS  PubMed  Google Scholar 

  18. Lee JS, Kritchevsky SB, Tylavsky F et al (2005) Weight change, weight change intention, and the incidence of mobility limitation in well-functioning community-dwelling older adults. J Gerontol A Biol Sci Med Sci 60(8):1007–1012

    Article  PubMed  Google Scholar 

  19. Mo Q, Lu SF, Simon NG (2006) Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. J Steroid Biochem Mol Biol 99(1):50–58

    Article  CAS  PubMed  Google Scholar 

  20. Nestler JE, Barlascini CO, Clore JN, Blackard WG (1988) Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66:57–61

    Article  CAS  PubMed  Google Scholar 

  21. Phillips AC, Carroll D, Gale CR, Lord JM, Arlt W, Batty GD (2010) Cortisol, DHEAS, their ratio and the metabolic syndrome: evidence from the Vietnam Experience Study. Eur J Endocrinol 162(5):919–923

    Article  CAS  PubMed  Google Scholar 

  22. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS et al (2006) Metaanalysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8:538–554

    Article  CAS  PubMed  Google Scholar 

  23. Savastano S, Belfiore A, Guida B, Angrisani L, Orio F, Cascella T, Milone F, Micanti F, Saldalamacchia G, Lombardi G, Colao A (2005) Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. J Endocrinol Invest 28(6):509–515

    Article  CAS  PubMed  Google Scholar 

  24. Schulman RA, Dean C (2007) DHEA (Dehydroepiandrosterone) is a common hormone produced in the adrenal glands, the gonads, and the brain. Solve it with supplements. Rodale, Inc, New York City, p 100

    Google Scholar 

  25. Tchernof A, Labrie F (2004) Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 151:1–14

    Article  CAS  PubMed  Google Scholar 

  26. Tchernof A, Poehlman ET (1998) Effects of the menopause transition on body fatness and body fat distribution. Obes Res 6:246–254

    Article  CAS  PubMed  Google Scholar 

  27. Thijssen JHH, Nieuwenhuyse H (1999) DHEA: a comprehensive review. Parthenon, Pearl River

    Google Scholar 

  28. Tsai MJ, O’Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451–486

    Article  CAS  PubMed  Google Scholar 

  29. Voelzke H, Aumann N, Krebs A, Nauck M, Steveling A, Lerch M, Rosskopf D, Wallaschofski H (2010) Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. Int J Androl 33(1):45–53

    Article  CAS  Google Scholar 

  30. Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM (2009) The association between dehydroepiandrosterone and frailty in older men and women. Age Ageing 38:401–406

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Walston J, McBurnie MA, Newman A et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162(20):2333–2341

    Article  PubMed  Google Scholar 

  32. Webb SJ, Geoghegan TE, Prough RA, Michael Miller KK (2006) The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 38(1–2):89–116

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. William F, Ganong MD (2005) Review of medical physiology, 22nd edn. McGraw Hill, USA, p 362

    Google Scholar 

Download references

Conflict of interest

There is no conflict interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Senay Topsakal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topsakal, S., Akin, F., Yerlikaya, E. et al. Dehydroepiandrosterone sulfate levels in Turkish obese patients. Eat Weight Disord 19, 261–265 (2014). https://doi.org/10.1007/s40519-014-0120-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40519-014-0120-9

Keywords

Navigation